245 related articles for article (PubMed ID: 28844780)
1. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
2. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
Tykocki T; Michalik R; Bonicki W; Nauman P
Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
[TBL] [Abstract][Full Text] [Related]
5. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
6. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
7. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
Morshed RA; Han SJ; Lau D; Berger MS
J Neurosurg; 2018 May; 128(5):1448-1453. PubMed ID: 28665248
[TBL] [Abstract][Full Text] [Related]
8. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
9. Image guided surgery for the resection of brain tumours.
Barone DG; Lawrie TA; Hart MG
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
[TBL] [Abstract][Full Text] [Related]
10. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
Lau D; Hervey-Jumper SL; Han SJ; Berger MS
J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
[TBL] [Abstract][Full Text] [Related]
12. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.
Sharma V; Kedia R; Narang KS; Jha AN
Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937
[TBL] [Abstract][Full Text] [Related]
13. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
14. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic Acid Imaging of Malignant Glioma.
Li G; Rodrigues A; Kim L; Garcia C; Jain S; Zhang M; Hayden-Gephart M
Surg Oncol Clin N Am; 2022 Oct; 31(4):581-593. PubMed ID: 36243495
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Coburger J; Wirtz CR
J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
19. To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
Díez Valle R; Tejada Solis S
CNS Oncol; 2015; 4(4):265-72. PubMed ID: 26118538
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.
Stummer W; Stepp H; Wiestler OD; Pichlmeier U
Neurosurgery; 2017 Aug; 81(2):230-239. PubMed ID: 28379547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
